Barts Cancer Institute

Queen Mary University of London

Driving Discoveries for Tomorrow's Cancer Care

Latest News from Barts Cancer Institute

Catch up with science, news and features from across the institute

Label
Digital illustration of a human face formed from small blue cubes, dispersing into a dark background.

PharosAI awarded funding to explore AI ‘digital twins’ of human tissue

PharosAI – a partnership between Queen Mary University of London, King’s College London and two NHS Trusts, Guy’s and St Thomas, and Barts Health – has received Innovate UK funding to explore whether AI can predict complex biological information from routinely collected tissue data. The project, called DESTINY, will investigate whether AI can predict molecular information that would otherwise require costly and time-consuming tests.

Grants & Awards · 15 October 2026

Our Research

Barts Cancer Institute is internationally renowned in multiple areas of cancer research. Our strength lies in our culture of close, multidisciplinary collaboration among our more than 350 research staff and 100 graduate students, based across 7 scientific centres and units:

  • Biomarkers & Biotherapeutics
  • Cancer Cell & Molecular Biology
  • Cancer Evolution
  • Haemato-oncology
  • Tumour Biology
  • Tumour Microenvironment
  • Experimental Cancer Medicine

Explore our centres

Explore the Institute

Learn how you could help drive cancer discoveries by working with us, studying with us, or engaging with us.

Latest Job Vacancies

Explore our current job openings at BCI and find the right opportunity for you.

Study with Us

Launch your career in cancer research with our postgraduate maters, diploma and doctorate programmes.

Public Engagement

Learn how we're sharing our knowledge and collaborating closely with patients and the public.